Header Logo

Connection

Peter Lindenauer to Community-Acquired Infections

Back to Details
This is a "connection" page, showing publications Peter Lindenauer has written about Community-Acquired Infections.
Peter Lindenauer
Connection Strength
4.134
Community-Acquired Infections
  1. Pulia MS, Griffin M, Schwei R, Pop-Vicas A, Schulz LT, Shieh MS, Pekow P, Vaughn VM, Lindenauer PK. Antibiotic Treatment in Patients Hospitalized for Nonsevere COVID-19. JAMA Netw Open. 2025 May 01; 8(5):e2511499.
    View in: PubMed
    Score: 0.916
  2. Rothberg MB, Imrey PB, Guo N, Deshpande A, Higgins TL, Lindenauer PK. A risk model to identify Legionella among patients admitted with community-acquired pneumonia: A retrospective cohort study. J Hosp Med. 2022 08; 17(8):624-632.
    View in: PubMed
    Score: 0.757
  3. Leyenaar JK, Shieh MS, Lagu T, Pekow PS, Lindenauer PK. Comparative effectiveness of ceftriaxone in combination with a macrolide compared with ceftriaxone alone for pediatric patients hospitalized with community-acquired pneumonia. Pediatr Infect Dis J. 2014 Apr; 33(4):387-92.
    View in: PubMed
    Score: 0.425
  4. Deshpande A, Klompas M, Guo N, Imrey PB, Pallotta AM, Higgins T, Haessler S, Zilberberg MD, Lindenauer PK, Rothberg MB. Intravenous to Oral Antibiotic Switch Therapy Among Patients Hospitalized With Community-Acquired Pneumonia. Clin Infect Dis. 2023 07 26; 77(2):174-185.
    View in: PubMed
    Score: 0.203
  5. Rothberg MB, Haessler S, Deshpande A, Yu PC, Lindenauer PK, Zilberberg MD, Higgins TL, Imrey PB. Derivation and validation of a risk assessment model for drug-resistant pathogens in hospitalized patients with community-acquired pneumonia. Infect Control Hosp Epidemiol. 2023 Jul; 44(7):1143-1150.
    View in: PubMed
    Score: 0.191
  6. Patel P, Deshpande A, Yu PC, Imrey PB, Lindenauer PK, Zilberberg MD, Haessler S, Rothberg MB. Association of fluoroquinolones or cephalosporin plus macrolide with Clostridioides difficile infection (CDI) after treatment for community-acquired pneumonia. Infect Control Hosp Epidemiol. 2023 01; 44(1):47-54.
    View in: PubMed
    Score: 0.186
  7. Haessler S, Guo N, Deshpande A, Zilberberg MD, Lagu T, Lindenauer PK, Imrey PB, Rothberg MB. Etiology, Treatments, and Outcomes of Patients With Severe Community-Acquired Pneumonia in a Large U.S. Sample. Crit Care Med. 2022 07 01; 50(7):1063-1071.
    View in: PubMed
    Score: 0.184
  8. Deshpande A, Klompas M, Yu PC, Imrey PB, Pallotta AM, Higgins T, Haessler S, Zilberberg MD, Lindenauer PK, Rothberg MB. Influenza Testing and Treatment Among Patients Hospitalized With Community-Acquired Pneumonia. Chest. 2022 09; 162(3):543-555.
    View in: PubMed
    Score: 0.183
  9. Ruhnke GW, Lindenauer PK, Lyttle CS, Meltzer DO. The Impact of Principal Diagnosis on Readmission Risk among Patients Hospitalized for Community-Acquired Pneumonia. Am J Med Qual. 2022 Jul-Aug 01; 37(4):307-313.
    View in: PubMed
    Score: 0.182
  10. Haessler S, Lindenauer PK, Zilberberg MD, Imrey PB, Yu PC, Higgins T, Deshpande A, Rothberg MB. Blood Cultures Versus Respiratory Cultures: 2 Different Views of Pneumonia. Clin Infect Dis. 2020 10 23; 71(7):1604-1612.
    View in: PubMed
    Score: 0.167
  11. Schimmel JJ, Haessler S, Imrey P, Lindenauer PK, Richter SS, Yu PC, Rothberg MB. Pneumococcal Urinary Antigen Testing in United States Hospitals: A Missed Opportunity for Antimicrobial Stewardship. Clin Infect Dis. 2020 09 12; 71(6):1427-1434.
    View in: PubMed
    Score: 0.166
  12. Gupta NM, Lindenauer PK, Yu PC, Imrey PB, Haessler S, Deshpande A, Higgins TL, Rothberg MB. Association Between Alcohol Use Disorders and Outcomes of Patients Hospitalized With Community-Acquired Pneumonia. JAMA Netw Open. 2019 06 05; 2(6):e195172.
    View in: PubMed
    Score: 0.152
  13. Dong T, Cursio JF, Qadir S, Lindenauer PK, Ruhnke GW. Discharge disposition as an independent predictor of readmission among patients hospitalised for community-acquired pneumonia. Int J Clin Pract. 2017 Mar; 71(3-4).
    View in: PubMed
    Score: 0.130
  14. Belforti RK, Lagu T, Haessler S, Lindenauer PK, Pekow PS, Priya A, Zilberberg MD, Skiest D, Higgins TL, Stefan MS, Rothberg MB. Association Between Initial Route of Fluoroquinolone Administration and Outcomes in Patients Hospitalized for Community-acquired Pneumonia. Clin Infect Dis. 2016 07 01; 63(1):1-9.
    View in: PubMed
    Score: 0.122
  15. Leyenaar JK, Lagu T, Shieh MS, Pekow PS, Lindenauer PK. Variation in resource utilization for the management of uncomplicated community-acquired pneumonia across community and children's hospitals. J Pediatr. 2014 Sep; 165(3):585-91.
    View in: PubMed
    Score: 0.108
  16. Haessler S, Lagu T, Lindenauer PK, Skiest DJ, Priya A, Pekow PS, Zilberberg MD, Higgins TL, Rothberg MB. Treatment Trends and Outcomes in Healthcare-Associated Pneumonia. J Hosp Med. 2017 11; 12(11):886-891.
    View in: PubMed
    Score: 0.034
  17. Rothberg MB, Haessler S, Lagu T, Lindenauer PK, Pekow PS, Priya A, Skiest D, Zilberberg MD. Outcomes of patients with healthcare-associated pneumonia: worse disease or sicker patients? Infect Control Hosp Epidemiol. 2014 Oct; 35 Suppl 3:S107-15.
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.